Amarin Corp. plc
(NASDAQ: AMRN)
|
8:00 PM UTC, 10/11/24 | |||
---|---|---|---|---|
Last: $0.59 | Change: +0.01 | %Change: +1.24% | Volume: 594,444 |
Open: | $ 0.58 | Volume: | 594,444 | |
---|---|---|---|---|
High: | $ 0.60 | Yield(%) | 0.00 | |
Low: | $ 0.58 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 238.45M | |
EPS ($) | -0.08 | Shares Out: | 411.11M |
% Price Change (last 4 weeks): | 0.17 |
---|---|
% Price Change (last 13 weeks): | -21.86 |
% Price Change (last 26 weeks): | -42.86 |
% Price Change (last 52 weeks): | -18.57 |
% Price Change (year to date): | -33.33 |
Return on Equity (%): | -10.34 |
---|---|
Return on Assets (%): | -6.91 |
Return on Invested Capital (%): | -6.79 |
Gross Profit Margin (%): | 65.75 |
---|---|
Net Profit Margin (%): | -19.26 |
Operating Profit Margin (%): | -5.67 |
50-day Moving Average: | $0.61 |
---|---|
200-day Moving Average: | $0.85 |
Avg. Daily Vol. (last 50 days): | 1,109,689 |
Avg. Daily Vol. (last 200 days): | 1,615,365 |
52-wk high: | $1.37 |
52-wk low: | $0.56 |
Bid: | $0.59 |
Ask: | $0.60 |
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
|
Amarin Corp. plc
Iconic Offices, The Greenway Block C Ardilaun Court, 112–114 St. Stephens Green Dublin DU 2 Phone: 353.1.6699.020 Fax: n/a http://www.amarincorp.com |
Earnings (1year) ($): | -0.08 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 1.35 |
Cash Flow ($): | -0.14 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 1.15 |
Price/Book (x): | 0.64 |
Price/Cash Flow (x): | 51.35 |
Quick Ratio (x): | 1.80 |
---|---|
Current Ratio (x): | 2.80 |
LT Debt/Equity (x): | 1.58 |
Total Debt/Equity (x): | 1.58 |